AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glucotaj Met 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Taj Pharma India Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glucotaj Met 1mg/500mg Tablet SR

Metformin/Sitagliptin 1mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, risking complications like kidney damage, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are key to effective diabetes control. Hypoglycemia (low blood sugar) is a frequent adverse effect. Learn to identify its symptoms (sweating, dizziness, headache, tremors) and implement appropriate countermeasures. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count, liver function tests) are recommended by your doctor.

Primary Ingredients of Glucotaj Met 1mg/500mg Tablet SR

No text was provided to rewrite.

Uses of Glucotaj Met 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glucotaj Met 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glucotaj Met 1mg/500mg SR Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Administer with food.

Common Side effects of Glucotaj Met 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glucotaj Met 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Glucotaj Met 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. It should be administered with a meal.

How Glucotaj Met 1mg/500mg Tablet SR works:

Glucotaj Met 1mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glucotaj Met 1mg/500mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glucotaj Met 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glucotaj Met 1mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glucotaj Met 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glucotaj Met 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glucotaj Met 1mg/500mg Tablet SR :

Should you forget a Glucotaj Met 1mg/500mg SR tablet, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed tablet and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Glucotaj Met 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glucotaj Met 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glucotaj Met 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glucotaj Met 1mg/500mg Tablet SR and seek immediate medical attention.
Glucotaj Met 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glucotaj Met 1mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glucotaj Met 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glucotaj Met 1mg/500mg SR tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glucotaj Met 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glucotaj Met 1mg/500mg Ta...
75
MRP 87
13% off